abstract |
Combinations, compositions, and kits are provided that include an immunoglobulin (IG) composition and a soluble hyaluronidase composition formulated for subcutaneous administration. Such products can be used in methods of treating diseases or conditions that can be treated with IG. Also provided is a method of subcutaneous administration of immunoglobulins whose dosage regime is substantially the same as for intravenous administration of the same dose to treat a disease or condition treatable with the IG. |